Remove FDA Remove Pharmaceutical Companies Remove Webinar
article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? For instance, the FDA’s requirement for Patient Perspectives in drug reviews has made patient engagement crucial for approvals and reimbursements.

article thumbnail

Operations Data Challenges Limit the Value Realized from Pharma 4.0

ISPE

To meet these challenges, pharmaceutical companies are accelerating digital transformation and making manufacturing more responsive to changing market conditions while improving efficiency. Pharma/Biopharma companies prefer a single system across a global manufacturing network, which further exacerbates this challenge.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Comprehensive Overview of Pharma Marketing Strategies

Pharma Marketing Network

With the advent of mass media, pharmaceutical companies began to explore direct-to-consumer (DTC) advertising, particularly through television and print ads. This shift allowed companies to communicate directly with patients, raising awareness about specific medical conditions and available treatments.

article thumbnail

Drug development and working with specialised Rare Disease networks

pharmaphorum

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs.

article thumbnail

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients

ISPE

The first keynote speaker was Michael Kopcha, PhD, RPh, Director of the Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US FDA. He presented on “Quality: A Key Ingredient for Stable Pharmaceutical Supply Chains.”. Director, Office of Pharmaceutical Quality. Tue, 11/01/2022 - 06:49.

FDA 98
article thumbnail

How Pharma-Funded Groups Lie About Personal Drug Imports

Policy Prescription

NeedyMeds , a non-profit organization known for providing patients with help in finding pharmaceutical company-sponsored prescription assistance programs and other drug savings options, hosted a webinar about drug importation last year called “ Drug Importation: The topic everyone’s talking about.” He replies “U.S.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. This on-demand webinar discusses the importance of a patient-appropriate BL & GF profile. Please check your email to download the Webinar.